What is this preparation and how is it positioned clinically?

It is a sterile intradermal injectable skin booster that combines polynucleotides with hyaluronic acid. Clinics position it in protocols focused on hydration support, elasticity, and overall skin-quality optimization. The dual composition allows teams to streamline sessions without mixing multiple products. It fits microinjection and mesotherapy-style workflows and can be planned across staged visits as part of broader aesthetic programs under medical direction. Use is limited to trained professionals in appropriate healthcare settings.

Which areas are commonly selected in professional protocols?

Clinics frequently target the face, periorbital periphery, forehead, cheeks, neck, and upper chest, adjusting technique to anatomy and skin thickness. Many providers focus on areas prone to dryness or reduced elasticity. Selection depends on clinical assessment, device choice, and session objectives. Some programs emphasize uniform coverage, while others prioritize specific zones. Final area selection, volume planning, and intervals should follow your facility’s protocols and applicable regulations.

How do polynucleotides and hyaluronic acid complement each other?

Polynucleotides are used to support normal dermal cell activity and tissue maintenance, helping create a favorable environment for skin quality. Hyaluronic acid contributes water-binding capacity and surface smoothness. Together, they enable a dual-action approach that addresses hydration along with dermal conditioning. This combination can simplify workflows compared with layering separate products. It is not intended to replace clinical judgment; providers should tailor plans to the individual case and device selection.

Can this product be combined with other treatments?

Clinics may combine it with compatible modalities in staged plans, such as energy-based devices, micro-needling, or thread procedures, when clinically appropriate. Sequencing is typically organized to respect tissue recovery and device-specific guidance. Space sessions according to your protocol, considering anatomy, skin reactivity, and program goals. Always evaluate interactions with other agents, and observe post-procedure care standards consistent with your practice’s policies and local regulations.

What comes in the box and how is it used operationally?

Packaging includes one syringe at 1 ml per unit for single use. The syringe format helps standardize chairside setup and aligns with common sharps handling procedures. Labels include lot and expiry identifiers to ease inventory checks. Teams can set reorder thresholds based on demand and session cadence. Use is restricted to trained clinicians; follow your facility’s handling and disposal procedures, and confirm compatibility with selected delivery devices before the session begins.

How should clinics manage storage and handling?

Follow the manufacturer’s storage instructions on the primary and secondary packaging. Keep units in their original cartons until use to protect sterility and traceability. Maintain a controlled environment per label guidance and track lot and expiry in your inventory system. Do not use compromised or opened units. Coordinate delivery timing with scheduled procedure days to minimize unnecessary handling and streamline in-room readiness.

What adverse events are typically monitored after intradermal injection?

Providers generally monitor for transient injection-site responses such as redness, tenderness, mild swelling, bruising, or small papules. These effects are usually localized and short-lived, resolving as the tissue settles. In line with your clinic’s protocols, advise clients on post-procedure care and signs that warrant review. Escalate any unexpected or persistent reactions according to your facility’s policies and applicable regulations. Always document treatment details in your medical record system.

Skin Boosters

Rejuran®HB

Rejuran® HB Skin Booster for Clinics

Name: Buy Rejuran® HB Skin Booster – US Distribution
SKU: 100121
Price: 152.99 USD
Availability: InStock

Skincare Product

$152.99

Description

An intradermal injectable skin booster combining polynucleotides and hyaluronic acid for professional aesthetic use. It supports moisture balance, elasticity, and overall skin quality in protocol-driven treatments, with US distribution. Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors.

What Rejuran Is and How It Works

Rejuran® HB pairs purified polynucleotides with hyaluronic acid in a sterile, single-use preparation designed for intradermal administration. Polynucleotides can support normal fibroblast activity and tissue-repair processes, helping maintain a healthy dermal environment. Hyaluronic acid provides sustained hydration and a smoother look by binding and retaining water within the dermis. Together, the class supports texture refinement and moisture balance across common aesthetic workflows. This product is intended for use by trained professionals following local guidelines.

This preparation fits well when clinics want a dual-action approach in a single syringe. It reduces the need to layer separate hydrators and regenerative adjuncts, which can simplify session planning. Teams can integrate it into structured protocols alongside other compatible devices and topicals according to clinical judgment.

Professional Applications

Clinics position this preparation in comprehensive aesthetic plans focused on dermal quality. Teams use it within microinjection and mesotherapy-style workflows to address dryness, reduced elasticity, or dull tone on the face, neck, and décolletage. Many protocols center on conservative dosing across multiple sessions under clinical judgment. The term Rejuran HB injection appears in professional documentation to describe this intradermal approach. For complementary options, visit Skin Boosters and see the overview in Rejuran Skin Booster.

Key Features

Dual-action synergy: PN for dermal support, HA for hydration
Intradermal route: designed for microinjection techniques
Professional-only use: sterile solution for clinical settings
Single-use format: streamlined prep and disposal
Smooth handling: suitable for fine-point techniques and micro-needling devices
Clear labeling: lot and expiry visibility to simplify checks
Device pairing: compatible with typical fine needles or microcannulas
Rejuran HB 1ml syringe: compact unit for predictable setup

Benefits in Practice

Clinics value predictable handling, session-to-session consistency, and a straightforward workflow. The dual composition reduces product mixing, which can help standardize appointment times. Teams can align intervals and coverage with existing protocols, minimizing complexity. Reported Rejuran HB benefits in practice include efficient hydration support, texture-focused planning, and convenient inventory control due to a single-use format. Because the formulation fits standard microinjection techniques, it can integrate easily with related modalities under medical direction. Where appropriate, clinicians may stage treatments with compatible topicals and devices for incremental gains over time.

Operationally, the preparation supports flexible scheduling. Facilities can allocate chair time and staff skills across a range of skin-quality programs without introducing new learning curves. Syringe-based delivery also aligns with established sharps handling and disposal procedures in most practices.

Composition & Ingredients

The formulation combines polynucleotides and hyaluronic acid in a buffered solution intended for intradermal use. In professional contexts, teams often note Rejuran HB ingredients PN when describing the regenerative component alongside HA’s hydrating role.

Active ingredients: Polynucleotides (PN); Hyaluronic acid (HA)
Excipients: Standard buffer solution for dermal injectables

Polynucleotides may support cellular processes involved in tissue maintenance, while hyaluronic acid contributes moisture retention and surface smoothness. This combination allows clinics to address hydration and dermal conditioning within one preparation.

Packaging & Supply

Each box contains 1 syringe × 1 ml (single-use). Unit-level packaging supports efficient stocking and quick procedural setup. Labels include key identifiers for lot control and expiry checks, aiding routine inventory management. The designation Rejuran HB skin booster is commonly used across clinic systems to distinguish this PN–HA format from standalone hydrating syringes.

For fine, uniform microinjection techniques, many teams pair this preparation with dedicated delivery tools. If needed, you can review compatible devices such as MicronJet to support standardized placement patterns.

Ordering & Logistics

Account verification is required. Sign in to view live inventory and volume or contract tiers. Many clinics set reorder points based on session cadence, staffing, and client flow. Education resources, including vendor datasheets and in-service training, can help orient clinical teams; for quick reference, see the earlier discussion on Rejuran HB how it works. For related PN–HA products and adjuncts, you can browse additional options via the links below.

Comparable Products

Clinics comparing PN- or HA-forward options often evaluate alternatives with similar workflow profiles. Consider Nucleofill 25 for PN-led protocols, or Plinest One when planning regenerative programs emphasizing dermal quality. For an HA-centric option, see RRS HA Long Lasting. Practices integrating threads can align treatment cycles with PDO Threads where clinically appropriate.

Pricing & Access

Sign in to view pricing. Volume and contract pricing are available for qualified accounts. Your account manager can assist with allocation planning, standing orders, and documentation for internal purchasing controls. Many facilities coordinate delivery windows with procedure days to simplify in-room readiness.

Availability & Substitutions

Supply can vary by demand and manufacturer release schedules. If a substitution is required, confirm compatibility with your clinical protocols, consent language, and inventory tracking. Consider PN-forward or HA-forward alternatives with similar handling characteristics. For broader options within this class, explore Skin Boosters. For supporting equipment decisions, see Cannulas And Needles.

Authoritative Sources

NIH Hyaluronic Acid Polynucleotides Review FDA Dermal Fillers

Sign in to order for your licensed practice and schedule deliveries aligned to your procedural calendar, supported by temperature-controlled handling when required and tracked US delivery.

Frequently Asked Questions

What is this preparation and how is it positioned clinically?
It is a sterile intradermal injectable skin booster that combines polynucleotides with hyaluronic acid. Clinics position it in protocols focused on hydration support, elasticity, and overall skin-quality optimization. The dual composition allows teams to streamline sessions without mixing multiple products. It fits microinjection and mesotherapy-style workflows and can be planned across staged visits as part of broader aesthetic programs under medical direction. Use is limited to trained professionals in appropriate healthcare settings.
Which areas are commonly selected in professional protocols?
Clinics frequently target the face, periorbital periphery, forehead, cheeks, neck, and upper chest, adjusting technique to anatomy and skin thickness. Many providers focus on areas prone to dryness or reduced elasticity. Selection depends on clinical assessment, device choice, and session objectives. Some programs emphasize uniform coverage, while others prioritize specific zones. Final area selection, volume planning, and intervals should follow your facility’s protocols and applicable regulations.
How do polynucleotides and hyaluronic acid complement each other?
Polynucleotides are used to support normal dermal cell activity and tissue maintenance, helping create a favorable environment for skin quality. Hyaluronic acid contributes water-binding capacity and surface smoothness. Together, they enable a dual-action approach that addresses hydration along with dermal conditioning. This combination can simplify workflows compared with layering separate products. It is not intended to replace clinical judgment; providers should tailor plans to the individual case and device selection.
Can this product be combined with other treatments?
Clinics may combine it with compatible modalities in staged plans, such as energy-based devices, micro-needling, or thread procedures, when clinically appropriate. Sequencing is typically organized to respect tissue recovery and device-specific guidance. Space sessions according to your protocol, considering anatomy, skin reactivity, and program goals. Always evaluate interactions with other agents, and observe post-procedure care standards consistent with your practice’s policies and local regulations.
What comes in the box and how is it used operationally?
Packaging includes one syringe at 1 ml per unit for single use. The syringe format helps standardize chairside setup and aligns with common sharps handling procedures. Labels include lot and expiry identifiers to ease inventory checks. Teams can set reorder thresholds based on demand and session cadence. Use is restricted to trained clinicians; follow your facility’s handling and disposal procedures, and confirm compatibility with selected delivery devices before the session begins.
How should clinics manage storage and handling?
Follow the manufacturer’s storage instructions on the primary and secondary packaging. Keep units in their original cartons until use to protect sterility and traceability. Maintain a controlled environment per label guidance and track lot and expiry in your inventory system. Do not use compromised or opened units. Coordinate delivery timing with scheduled procedure days to minimize unnecessary handling and streamline in-room readiness.
What adverse events are typically monitored after intradermal injection?
Providers generally monitor for transient injection-site responses such as redness, tenderness, mild swelling, bruising, or small papules. These effects are usually localized and short-lived, resolving as the tissue settles. In line with your clinic’s protocols, advise clients on post-procedure care and signs that warrant review. Escalate any unexpected or persistent reactions according to your facility’s policies and applicable regulations. Always document treatment details in your medical record system.

Specifications

Main Ingredient: Hyaluronic Acid, Polynucleotides
Manufacturer: Pharma Research Products
Drug Class: Skincare Product
Generic Name: Polynucleotides (PN), Hyaluronic acid (HA)
Package Contents: 1 mL x 1 Pre-Filled Syringe
Storage Requirements: Room Temperature (2℃~25℃)
Main Usage: Hydration, Moisturiser, Hydrating

Here to help

Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager

International Shipping

Seamless delivery across the world

Easy Returns

Flexible solutions with our 30 day return policy

Secure Payments

Order confidently with private security network